Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center

Journal of Hepatology - Tập 47 - Trang 239-244 - 2007
Ji Young Lee1, Kang Mo Kim1, Sung Gyu Lee2, Eunsil Yu3, Young-Suk Lim1, Han Chu Lee1, Young-Hwa Chung1, Yung Sang Lee1, Dong-Jin Suh1
1Department of Internal Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Republic of Korea
2Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Republic of Korea
3Department of Pathology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Republic of Korea

Tài liệu tham khảo

Pagano, 2002, Non-alcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association, Hepatology, 35, 367, 10.1053/jhep.2002.30690 Marchesini, 2003, Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161 Marchesini, 1999, Association of non-alcoholic fatty liver disease with insulin resistance, Am J Med, 107, 450, 10.1016/S0002-9343(99)00271-5 Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004 Bugianesi, 2002, Expanding the natural history of non-alcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168 Ratziu, 2002, Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis, Hepatology, 35, 1485, 10.1053/jhep.2002.33324 Marsman, 1996, Use of fatty donor liver is associated with diminished early patient and graft survival, Transplantation, 62, 1246, 10.1097/00007890-199611150-00011 Verran, 2003, Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation, Liver Transpl, 9, 500, 10.1053/jlts.2003.50099 Behrns, 1998, Hepatic steatosis as a potential risk factor for major hepatic resection, J Gastrointest Surg, 2, 292, 10.1016/S1091-255X(98)80025-5 Marcos, 2000, Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation, Transplantation, 69, 1375, 10.1097/00007890-200004150-00028 Castera, 1999, Pain experienced during percutaneous liver biopsy, Hepatology, 30, 1529, 10.1002/hep.510300624 Gilmore, 1995, Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London, Gut, 36, 437, 10.1136/gut.36.3.437 Saadeh, 2002, The utility of radiological imaging in non-alcoholic fatty liver disease, Gastroenterology, 123, 745, 10.1053/gast.2002.35354 Graif, 2000, Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease, Invest Radiol, 35, 319, 10.1097/00004424-200005000-00006 WHO/IASO/IOTF. The Asian-Pacific perspective: redefining obesity and its treatment. Health Communications Australia: Melbourne. ISBN 0-9577082-1-1. 2000. Contos, 2004, The histologic spectrum of non-alcoholic fatty liver disease, Clin Liver Dis, 8, 481, 10.1016/j.cld.2004.04.013 Kleiner, 2005, Design and validation of a histological scoring system for non-alcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Brunt, 1999, Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am J Gastroenterol, 94, 2467, 10.1111/j.1572-0241.1999.01377.x Hwang, 2004, The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation, Liver Transpl, 10, 721, 10.1002/lt.20172 Ryan, 2002, One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation, Liver Transpl, 8, 1114, 10.1053/jlts.2002.36740 el-Hassan, 1992, Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management, Br J Radiol, 65, 774, 10.1259/0007-1285-65-777-774 Fan, 2005, Prevalence of and risk factors for fatty liver in a general population of Shanghai, China, J Hepatol, 43, 508, 10.1016/j.jhep.2005.02.042 Wanless, 1990, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors, Hepatology, 12, 1106, 10.1002/hep.1840120505 Diehl, 1988, Alcohollike liver disease in non-alcoholics. A clinical and histologic comparison with alcohol-induced liver injury, Gastroenterology, 95, 1056, 10.1016/0016-5085(88)90183-7 Ludwig, 1980, Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease, Mayo Clin Proc, 55, 434 Bacon, 1994, Non-alcoholic steatohepatitis: an expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6 Donati, 2004, Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance, Gut, 53, 1020, 10.1136/gut.2003.027086 Marceau, 1999, Liver pathology and the metabolic syndrome X in severe obesity, J Clin Endocrinol Metab, 84, 1513, 10.1210/jc.84.5.1513 Weston, 2005, Racial and ethnic distribution of non-alcoholic fatty liver in persons with newly diagnosed chronic liver disease, Hepatology, 41, 372, 10.1002/hep.20554 Park, 2001, Larger amounts of visceral adipose tissue in Asian Americans, Obes Res, 9, 381, 10.1038/oby.2001.49 Wang, 1994, Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements, Am J Clin Nutr, 60, 23, 10.1093/ajcn/60.1.23 Mofrad, 2003, Clinical and histologic spectrum of non-alcoholic fatty liver disease associated with normal ALT values, Hepatology, 37, 1286, 10.1053/jhep.2003.50229 Brandhagen, 2003, Evaluation of the donor liver for living donor liver transplantation, Liver Transpl, 9, S16, 10.1053/jlts.2003.50222 Hwang, 2006, Lessons learned from 1000 living donor liver transplantations in a single center: how to make living donation safe, Liver Transpl, 12, 920, 10.1002/lt.20734